Seniors Health Investigation Network - Blood Pressure Monitoring Program
| ISRCTN | ISRCTN61739603 |
|---|---|
| DOI | https://doi.org/10.1186/ISRCTN61739603 |
| Protocol serial number | N/A |
| Sponsor | Biovail Pharmaceuticals Canada, formerly Crystaal Corporation |
| Funder | Biovail Corporation Canada, formerly Crystaal Corporation |
- Submission date
- 27/05/2005
- Registration date
- 01/06/2005
- Last edited
- 15/04/2008
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Circulatory System
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Plain English summary of protocol
Not provided at time of registration
Contact information
Dr Janusz Kaczorowski
Scientific
Scientific
1200 Main Street West HSC-2V12
Hamilton
L8N 3Z5
Canada
Study information
| Primary study design | Interventional |
|---|---|
| Study design | Randomised controlled trial |
| Secondary study design | Single-centre |
| Scientific title | |
| Study acronym | SHINE - Dundas Pilot |
| Study objectives | To determine the best method (mail or telephone) for family physicians offices to invite patients to attend a session, and to identify factors that predicted attendance. In preparation for a larger scale randomized controlled trial, we also performed a cost analysis of invitation method and success rate, investigated the operational and methodological aspects of the proposed intervention, and queried patients willingness to continue to attend community pharmacy blood pressure sessions and their preferences for the time and frequency of the sessions. |
| Ethics approval(s) | Not provided at time of registration |
| Health condition(s) or problem(s) studied | Hypertension |
| Intervention | Regular patients 65 years or older (n = 235) were randomly allocated to invitation by mail or telephone to attend pharmacy cardiovascular health awareness sessions led by volunteer peer health educators. |
| Intervention type | Other |
| Primary outcome measure(s) |
The primary end-point |
| Key secondary outcome measure(s) |
Not provided at time of registration |
| Completion date | 27/04/2001 |
Eligibility
| Participant type(s) | Patient |
|---|---|
| Age group | Senior |
| Sex | All |
| Target sample size at registration | 235 |
| Key inclusion criteria | Patients were eligible to participate if they were 65 years of age or older, considered by the physician to be regular patients, community dwelling, and able to attend a cardiovascular health promotion session in a local pharmacy. |
| Key exclusion criteria | Patients were excluded if they suffered from dementia or a serious, non-cardiovascular disease or condition, or were non-English speaking and could not attend with an English-speaking companion. |
| Date of first enrolment | 01/03/2001 |
| Date of final enrolment | 27/04/2001 |
Locations
Countries of recruitment
- Canada
Study participating centre
1200 Main Street West HSC-2V12
Hamilton
L8N 3Z5
Canada
L8N 3Z5
Canada
Results and Publications
| Individual participant data (IPD) Intention to share | No |
|---|---|
| IPD sharing plan summary | Not provided at time of registration |
| IPD sharing plan |
Study outputs
| Output type | Details | Date created | Date added | Peer reviewed? | Patient-facing? |
|---|---|---|---|---|---|
| Results article | Results: | 19/08/2005 | Yes | No |